Neuberger Berman Group’s Enzo Biochem, Inc. ENZ Stock Holding History

Neuberger Berman Group’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10,836	Closed	-$38K	–	1966
2021 Q3	$38K	Buy	+10,836	New	+$36.1K	﹤0.01%	1744
2020 Q4	–	Sell	-22,333	Closed	-$47K	–	1736
2020 Q3	$47K	Hold	22,333	–	–	﹤0.01%	1612
2020 Q2	$50K	Hold	22,333	–	–	﹤0.01%	1526
2020 Q1	$57K	Hold	22,333	–	–	﹤0.01%	1503
2019 Q4	$59K	Hold	22,333	–	–	﹤0.01%	1520
2019 Q3	$80K	Sell	22,333 -280	-1%	-$991	﹤0.01%	1515
2019 Q2	$76K	Hold	22,613	–	–	﹤0.01%	1528
2019 Q1	$62K	Hold	22,613	–	–	﹤0.01%	1499
2018 Q4	$63K	Hold	22,613	–	–	﹤0.01%	1557
2018 Q3	$93K	Hold	22,613	–	–	﹤0.01%	1606
2018 Q2	$117K	Hold	22,613	–	–	﹤0.01%	1676
2018 Q1	$124K	Sell	22,613 -501	-2%	-$3.53K	﹤0.01%	1645
2017 Q4	$188K	Sell	23,114 -781	-3%	-$7.46K	﹤0.01%	1701
2017 Q3	$250K	Hold	23,895	–	–	﹤0.01%	1461
2017 Q2	$264K	Sell	23,895 -242	-1%	-$2.25K	﹤0.01%	1446
2017 Q1	$202K	Sell	24,137 -89	-0.4%	-$627	﹤0.01%	1535
2016 Q4	$168K	Hold	24,226	–	–	﹤0.01%	1549
2016 Q3	$123K	Hold	24,226	–	–	﹤0.01%	1556
2016 Q2	$145K	Hold	24,226	–	–	﹤0.01%	1494
2016 Q1	$110K	Hold	24,226	–	–	﹤0.01%	1463
2015 Q4	$109K	Hold	24,226	–	–	﹤0.01%	1465
2015 Q3	$77K	Hold	24,226	–	–	﹤0.01%	1505
2015 Q2	$73K	Hold	24,226	–	–	﹤0.01%	1544
2015 Q1	$71K	Hold	24,226	–	–	﹤0.01%	1587
2014 Q4	$107K	Hold	24,226	–	–	﹤0.01%	1616
2014 Q3	$125K	Sell	24,226 -781	-3%	-$4.17K	﹤0.01%	1611
2014 Q2	$131K	Buy	+25,007	New	+$108K	﹤0.01%	1662

Other funds holding ENZ

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VCA

VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Neuberger Berman Group's ENZ Position: Q4 2021 in Review

Neuberger Berman Group sold out of Enzo Biochem, Inc. (ENZ) in Q4 2021, closing a stake of 10,836 shares — an estimated $38K sold.

Neuberger Berman Group first reported a position in ENZ in Q2 2014 and held it in 27 quarters. The position peaked at $264K in Q2 2017. 59 funds tracked by Wall St. Rank hold ENZ as of Q4 2021.

Neuberger Berman Group reported no remaining Enzo Biochem, Inc. position as of Q4 2021 after selling out during the quarter.
Neuberger Berman Group sold 10,836 Enzo Biochem, Inc. shares in Q4 2021, an estimated $38K.
Neuberger Berman Group first reported a position in Enzo Biochem, Inc. in Q2 2014 and held it in 27 quarters.
Neuberger Berman Group's Enzo Biochem, Inc. position peaked at $264K in Q2 2017.
59 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q4 2021.

Based on Neuberger Berman Group's 13F filing for Q4 2021, filed 11 Feb 2022.